| 1 |
35070994 | Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology. | 2021 |
1 |
| 2 |
32143967 | Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study. | 2020 Sep |
4 |
| 3 |
31360064 | Successful long-term treatment of non-small cell lung cancer positive for RET rearrangement with pemetrexed. | 2019 |
5 |
| 4 |
31431614 | HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer. | 2019 Aug 20 |
1 |
| 5 |
29128428 | Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer. | 2018 Jan |
1 |
| 6 |
27056998 | Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers. | 2016 Jul |
4 |
| 7 |
27794403 | Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma. | 2016 Nov |
1 |